Illumina's Verinata Health presents verifi data


Illumina's (ILMN) Verinata Health publishes peer-reviewed verifi data which the company says "validates [its] approach to non-invasive prenatal testing."

The data show verifi correctly detected aneuploidies (that's a chromosome abnormality) "across all test samples."

Verinata says this shows testing "based on deeper sequencing delivers highly accurate results regardless of the variation in fetal fraction." (PR)

From other sites
Comments (2)
  • Director one
    , contributor
    Comments (62) | Send Message
     
    Why hasn't ILMN bought SQNM yet.?........They would lockup the whole area..........They have the funds to do it....Let alone SQNM can be had for a low price.
    19 Sep 2013, 08:09 AM Reply Like
  • Sumit Aggarwal
    , contributor
    Comments (7) | Send Message
     
    Why buy SQNM when they can crush them with predatory pricing and marketing muscle. Just like they did with GNOM
    19 Sep 2013, 09:02 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs